- Advanced search
- Immuno Portal
- Malaria Portal
Synonyms: BMS 663513 | BMS-663513
Compound class: Antibody
Comment: Urelumab (BMS-663513) a fully human lgG4 monoclonal antibody with agonist activity at the tumour necrosis factor (TNF) receptor, 4-1BB (TNFRSF9). It is being investigated for potential clinical immunostimulatory activity in the immuno-oncology setting [2-4].
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record. Peptide sequences for urelumab are identical matches for peptides claimed in patent WO2005035584, which leads to identification of clone 20H4-9-IgG4 .
Ligand Activity Visualisation Charts
These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.✖
|International Nonproprietary Names|
|BMS 663513 | BMS-663513|
|GtoPdb PubChem SID||318164830|
|Search PubMed clinical trials||urelumab|
|Search PubMed titles||urelumab|
|Search PubMed titles/abstracts||urelumab|